Tuesday, November 10, 2026
Home Authors Posts by Ogkologos

Ogkologos

4396 POSTS 0 COMMENTS

EMA Recommends Extension of Indications for Ibrutinib

Ogkologos -
0

ESMO Highlights the Importance of Prioritising the Fight Against Cancer in...

Ogkologos -
0

ESMO Urges EU Policymakers to Protect the Wellbeing of the Oncology...

Ogkologos -
0

Adding Lenvatinib to Pembrolizumab Does Not Provide Additional Benefit in Patients...

Ogkologos -
0

ESMO awards its first fellowship to support digital and computational pathology

Ogkologos -
0

Although Not Improving DFS, Adjuvant Avelumab May Potentially Reduce the Risk...

Ogkologos -
0

Patients with Early-Onset CRC More Often Diagnosed at Advanced Stage of...

Ogkologos -
0

A toolkit to address disparities in digitally enabled oncology trials

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Vimseltinib

Ogkologos -
0

Exceptional Response to Single-Agent Anti-PD1 Therapy Observed in Patients with Advanced...

Ogkologos -
0
1...394041...440Page 40 of 440

MOST POPULAR

Load more

HOT NEWS

Information on cancer, treatments, support and developments in oncology.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2026 Ogkologos.com